Category: Uncategorized
CDC Info on Zika
- Zika Cases in the United States
- Congenital Zika Syndrome and Other Birth Defects
- Clinical Considerations for Pregnant Women with Possible Zika Virus Infection | Zika Virus | CDC
- Testing for Zika
- Preventing Zika
- How Zika Spreads
- Zika Symptoms and Complications
- Protecting Workers from Zika
- Work outdoors? Protect yourself!
- Know before you go!
Zika virus Articles:
- A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trial
- Ten Years of Congenital Zika Syndrome: From Outbreak to a Decade of Clinical, Therapeutic, and Preventive Advances in a Tropical Disease Context
- Discordant imaging findings in dizygotic twins with known exposure to maternal ZIKV infection during initial stages of pregnancy
- Organoids: From Bench to Bedside Applications
- E-protein variability in Zika virus strains: A possible new O-glycosylation site and its implications
- Zika virus recruits karyopherin alpha6 for efficient replication via NS2B
- Zika Virus Infection
- An engineered viral RNA degrader on mitochondrial surface that mitigates RNA virus infection
- Spatially Resolved Microglial State Transitions Govern Strain-Specific Zika Neuropathogenesis
- Coupled Binding and Folding of NS2B/NS3 Protease and Linker Effects Revealed by Topology-based Modeling
Latest on Zika virus
- A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trial
- E-protein variability in Zika virus strains: A possible new O-glycosylation site and its implications
- Zika virus recruits karyopherin alpha6 for efficient replication via NS2B
- Zika Virus Infection
- MicroRNA-124-targeted recombinant Zika virus: a dual-functional and safe candidate for vaccination and oncolytic virotherapy
Latest on dengue virus
- Temporal Machine Learning Models for Classifying Suspected Dengue Cases in Mexico Using Surveillance Data from 2025
- Intention to Receive the TAK-003 Dengue Vaccine and Associated Factors Among Adults in Rural Northern Thailand
- TTV Viremia and Immune Responses Following Vaccination Against Mpox and Dengue Viruses
- Dengue NS1 as a Driver of Immune-Mediated Pathogenesis
- The impact of elevation and population density on dengue incidence and force of infection across the Philippines: Implications for climate-adapted surveillance